Helping People Survive with Bladder Urothelial Carcinoma
common.study.values.description
“A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival”
The investigators would like to compare the progression free survival, overall survival, quality of life, and safety outcomes of patients receiving versus not receiving a 2nd transurethral resection of bladder tumor.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Procedure - re-TURBT
2nd bladder biopsy within 4-6 weeks of initial biopsy
Drug - 6 weeks BCG instillation
standard 6 weeks of BCG induction
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Pilot, Single-centre, Randomized, 5-year, Parallel-group, Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
common.study.values.clinical-trial-id
NCT03266900
participant.views.study.view.id
9av4Vd
